A detailed history of Macquarie Group LTD transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 129,823 shares of TMO stock, worth $79.7 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
129,823
Previous 130,631 0.62%
Holding current value
$79.7 Million
Previous $75.9 Million 5.44%
% of portfolio
0.08%
Previous 0.09%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$541.52 - $599.02 $437,548 - $484,008
-808 Reduced 0.62%
129,823 $71.8 Million
Q1 2024

May 14, 2024

SELL
$528.82 - $599.43 $1.83 Million - $2.08 Million
-3,469 Reduced 2.59%
130,631 $75.9 Million
Q4 2023

Feb 14, 2024

SELL
$431.41 - $532.94 $8.67 Million - $10.7 Million
-20,092 Reduced 13.03%
134,100 $71.2 Million
Q3 2023

Nov 14, 2023

BUY
$498.29 - $574.41 $9.87 Million - $11.4 Million
19,799 Added 14.73%
154,192 $78 Million
Q2 2023

Aug 14, 2023

SELL
$508.46 - $591.13 $11 Million - $12.8 Million
-21,608 Reduced 13.85%
134,393 $70.1 Million
Q1 2023

May 15, 2023

SELL
$535.0 - $604.82 $29.5 Million - $33.3 Million
-55,053 Reduced 26.08%
156,001 $89.9 Million
Q4 2022

Feb 21, 2023

SELL
$484.71 - $571.37 $79,007 - $93,133
-163 Reduced 0.08%
211,054 $116 Million
Q3 2022

Nov 14, 2022

SELL
$507.19 - $604.49 $7.75 Million - $9.23 Million
-15,273 Reduced 6.74%
211,217 $107 Million
Q2 2022

Aug 15, 2022

SELL
$500.9 - $612.21 $35.9 Million - $43.9 Million
-71,632 Reduced 24.03%
226,490 $123 Million
Q1 2022

May 16, 2022

BUY
$524.0 - $644.92 $39.5 Million - $48.7 Million
75,455 Added 33.89%
298,122 $176 Million
Q4 2021

Feb 11, 2022

SELL
$569.0 - $667.24 $3.95 Million - $4.63 Million
-6,936 Reduced 3.02%
222,667 $149 Million
Q3 2021

Nov 12, 2021

SELL
$509.53 - $609.78 $8.89 Million - $10.6 Million
-17,454 Reduced 7.06%
229,603 $131 Million
Q2 2021

Aug 13, 2021

BUY
$441.0 - $508.24 $29.1 Million - $33.6 Million
66,021 Added 36.47%
247,057 $125 Million
Q1 2021

May 14, 2021

SELL
$439.85 - $518.83 $6.98 Million - $8.23 Million
-15,871 Reduced 8.06%
181,036 $82.6 Million
Q4 2020

Feb 16, 2021

BUY
$435.06 - $527.66 $10.2 Million - $12.4 Million
23,496 Added 13.55%
196,907 $91.7 Million
Q3 2020

Nov 13, 2020

SELL
$359.77 - $441.52 $1.62 Million - $1.99 Million
-4,509 Reduced 2.53%
173,411 $76.6 Million
Q2 2020

Aug 11, 2020

SELL
$275.2 - $362.34 $1.02 Million - $1.35 Million
-3,723 Reduced 2.05%
177,920 $64.5 Million
Q1 2020

May 15, 2020

SELL
$255.3 - $340.05 $6.98 Million - $9.29 Million
-27,322 Reduced 13.07%
181,643 $51.5 Million
Q4 2019

Feb 14, 2020

BUY
$271.93 - $328.04 $6.34 Million - $7.65 Million
23,308 Added 12.55%
208,965 $67.9 Million
Q3 2019

Nov 14, 2019

BUY
$268.46 - $305.43 $397,589 - $452,341
1,481 Added 0.8%
185,657 $54.1 Million
Q2 2019

Aug 14, 2019

BUY
$257.51 - $295.55 $233,819 - $268,359
908 Added 0.5%
184,176 $54.1 Million
Q1 2019

May 15, 2019

SELL
$212.17 - $273.72 $1.39 Million - $1.79 Million
-6,546 Reduced 3.45%
183,268 $50.2 Million
Q4 2018

Feb 15, 2019

SELL
$208.47 - $251.98 $2.5 Million - $3.03 Million
-12,009 Reduced 5.95%
189,814 $42.5 Million
Q3 2018

Nov 15, 2018

SELL
$205.57 - $244.32 $2.12 Million - $2.52 Million
-10,315 Reduced 4.86%
201,823 $49.3 Million
Q2 2018

Aug 14, 2018

SELL
$203.14 - $219.53 $644,766 - $696,788
-3,174 Reduced 1.47%
212,138 $43.9 Million
Q1 2018

May 11, 2018

BUY
$192.98 - $224.11 $137,980 - $160,238
715 Added 0.33%
215,312 $44.5 Million
Q4 2017

Feb 15, 2018

BUY
$182.03 - $200.37 $8.42 Million - $9.26 Million
46,239 Added 27.46%
214,597 $40.4 Million
Q3 2017

Nov 08, 2017

BUY
$171.74 - $194.04 $28.9 Million - $32.7 Million
168,358
168,358 $31.9 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $241B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.